News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–66
- Matches
- 66
- Sources here
- 16
- Companies here
- 3
Active search
66 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Avoiding Lag: Real-Time Signals in (PBH) Movement
This article provides a real-time analysis of Prestige Consumer Healthcare Inc. (NYSE: PBH) stock movements, highlighting strong near- and mid-term positive sentiment but a weak long-term outlook. It identifies key resistance levels and offers institutional trading strategies including position, momentum breakout, and risk hedging, …
Price to sales forward of Prestige Consumer Healthcare Inc. – NYSE:PBH
This article provides financial data for Prestige Consumer Healthcare Inc. (NYSE: PBH), specifically its price-to-sales forward metric. The content appears to be a financial snapshot from a trading platform, indicating market status and general financial information for the company.
Prestige Consumer Number of Employees 2026 | Employee Count & Headcount Data
Prestige Consumer Healthcare, Inc. (PBH) had 897 employees worldwide as of March 2026, representing a 10.6% growth since 2023. The company is actively hiring, although job postings declined by 2.7% in 2026 compared to 2025. Its workforce is primarily concentrated in the United States, …
PBH|Prestige Consumer Healthcare Inc|Price:52.180|Chg%:+0.460
Prestige Consumer Healthcare Inc. (PBH) shows healthy fundamentals and high growth potential, with its valuation considered fairly priced within the Pharmaceuticals industry. Institutional ownership is notably high, and analysts have consistently rated the stock as "Buy," with a target price of $66.00. Despite strong …
Prestige Consumer Healthcare Inc (PBH) Institutional Confidence
Prestige Consumer Healthcare Inc (PBH) has a strong institutional confidence score of 10.00, placing it first in the Pharmaceuticals industry. The institutional shareholding proportion has increased to 121.63%, with John Rogers being the largest institutional shareholder. Several major institutional investors hold significant shares, with …
Prestige Consumer Healthcare Inc (PBH) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides general information on Prestige Consumer Healthcare Inc (PBH) regarding its dividends and stock splits. It states that the company has distributed $0.00 in dividends over the past five years and contains a section for the dividend timeline, which currently shows no …
PBH Income Statement
This article provides a detailed quarterly and annual income statement for Prestige Consumer Healthcare Inc (PBH), enabling users to analyze the company's financial performance and operational efficiency. It covers key metrics like revenue, operating profit, and net income, alongside year-over-year comparisons. The page also …
Prestige Consumer Healthcare Inc Revenue Breakdown – FWB:PBV
Prestige Consumer Healthcare Inc. (FWB:PBV) generated 942.30 million EUR in revenue last year. The majority of this revenue, 790.72 million EUR, came from its North American Over-the-counter Healthcare segment. The United States was the primary contributor to revenue, accounting for 736.05 million EUR.
Prestige Consumer Healthcare Inc
This article provides a brief overview of Prestige Consumer Healthcare Inc (PBH), including its stock performance, market capitalization, and P/E ratio. It also details the company's revenue breakdown by region for a past fiscal year, showing a significant portion comes from the United States, …
PREMIUM BRANDS HOLDINGS CORPORATION TO RELEASE SECOND QUARTER 2026 RESULTS
VANCOUVER, BC, July 22, 2026 /CNW/ -- Premium Brands Holdings Corporation (TSX: PBH) (the "Company"), a leading producer, marketer and distributor of branded specialty food products, will release its second quarter 2026 results on Thursday, August 6, 2026. Pre-recorded Management Remarks, Press Release and …
Discipline and Rules-Based Execution in PBH Response
This article analyzes Prestige Consumer Healthcare Inc. (NYSE: PBH) using AI models, identifying a potential shift in positive near-term sentiment and broader weak alignment. It highlights an exceptional risk-reward short setup and provides institutional trading strategies for different risk profiles, including position, momentum breakout, …
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring A 33.81% Potential Upside
Prestige Consumer Healthcare (PBH) is a significant player in the healthcare sector, offering over-the-counter health and personal care products. Despite a recent revenue growth decline, the company shows potential for recovery with a promising 33.81% upside based on analyst targets, an attractive forward P/E …
how InvestingPro’s fair value spotted Prestige Healthcare’s 42% drop
InvestingPro's Fair Value analysis accurately predicted a 42% drop in Prestige Consumer Healthcare Inc. (PBH) stock. In February 2025, when PBH was trading at $86.12, InvestingPro flagged it as 41% overvalued with an intrinsic worth of $50.69. This prediction was validated sixteen months later …
Prestige Consumer Healthcare (NYSE: PBH) issues $400M 2034 notes
Prestige Consumer Healthcare Inc., through its subsidiary Prestige Brands, Inc., announced the issuance of $400 million of 6.250% senior unsecured notes due July 15, 2034. These notes, guaranteed by the company and its domestic restricted subsidiaries, will pay interest semiannually starting January 15, 2027. …